Multiple bacterial enzymes and cell wall proteins

The designation "Multiple bacterial enzymes and cell wall proteins" is a broad, umbrella term that refers to a class of proteins central to bacterial cell wall synthesis, remodeling, and integrity. These include various enzymes such as penicillin-binding proteins (PBPs), peptidoglycan hydrolases, transpeptidases, transglycosylases, carboxypeptidases, and several proteases, as well as structural and regulatory cell wall proteins. They play essential roles in bacterial growth, cell division, morphogenesis, and virulence, making them key targets for many classes of antibiotics and novel antibacterial agents. However, this term is non-specific and refers to multiple distinct molecular entities rather than a single defined target, so it is not suitable as a precise canonical target name. Therapeutic interventions exploit the unique presence and structure of these proteins in bacteria to selectively disrupt pathogenic organisms while minimizing effects on mammalian cells; β-lactam and glycopeptide antibiotics, as well as new biological agents (such as endolysins and antibody-antibiotic conjugates), act on various components of this group. Challenges include the diversity of resistance mechanisms and the need for high specificity to avoid collateral damage to beneficial microbiota or induction of immune responses. Note: - This "target" is too broad for use as a specific canonical entry; it comprises multiple protein families and enzyme types. - For structured data or drug development, mapping to individual, well-defined targets (e.g., "Penicillin-binding protein 2a", "N-acetylmuramoyl-L-alanine amidase") is necessary.

Other names

Peptidoglycan enzymescell wall biosynthesis enzymespenicillin-binding proteins (PBPs)bacterial proteaseslytic transglycosylasesautolysinscell wall hydrolasescell wall remodeling enzymes

Inhibition of peptidoglycan synthesis (by targeting PBPs, transpeptidases, transglycosylases); Hydrolysis of existing cell wall components (by hydrolases such as endolysins and autolysins); Inhibition of protease function (blocking vital protein turnover for cell wall maintenance or virulence); Disruption of cell wall integrity (by monoclonal antibodies or therapeutic peptides)